Ileal Inflammation May Trigger the Development of GP2-Specific Pancreatic Autoantibodies in Patients with Crohn’s Disease

<table>Anti-GP2 antibody titres in 225 patients with Crohn’s disease (CD) stratified in two groups: patients with restricted colonic location (L2) and patients with ileal (ileal or ileocolonic) location (L1 and L3), according to Montreal classification.</table>

Journal of Immunology Research

fig2

Figure 2

Figure 2: Ileal Inflammation May Trigger the Development of GP2-Specific Pancreatic Autoantibodies in Patients with Crohn’s Disease 